Rivaroxaban axapharm vascular 2.5 mg, Filmtabletten - 196 Swissmedic Key 69438002 Registration Holder axapharm ag Name Rivaroxaban axapharm vascular 2.5 mg, Filmtabletten Date of registration 20.12.2024 Introduction of Sequence 20.12.2024 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 19.12.2029 Index Therapeuticus (BSV) Show package size 196 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680694380027 Medication Code Synthetika Pharmacode Disponibility
Composition Filmtablette: rivaroxabanum 2.5 mg, cellulosum microcristallinum, lactosum monohydricum 26.46 mg, natrii laurilsulfas, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (flavum), pro compresso obducto corresp. natrium 0.27 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose additional_information Rivaroxabanum 2.5 mg Filmtablette
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Überzug Lactose Monohydrate 26.46 mg Macrogol 400 Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto
Source Data was imported : 07.01.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :